论文部分内容阅读
本刊讯(通讯员林峰)由第二军医大学附属东方肝胆外科医院吴孟超院士领衔、杨家和等知名教授组成的医疗专家团队经过12年的探索和努力,近期开拓性地提出了肝肠同时切除,再通过化疗、微创、生物等多种手段并举治疗,可解决困扰医学界多年的肠癌肝转移治疗难题。通过对近600例患者的术后随访,发现术后5年生存率上升到50%,达到国际先进
The magazine (correspondent Lin Feng) by the Second Military Medical University Affiliated Hepatobiliary Surgery Hospital led by academician Wu Mengchao, Yang Jiahe and other famous professors composed of medical experts team after 12 years of exploration and efforts, recently pioneered the simultaneous removal of liver and intestine, And then through chemotherapy, minimally invasive, biological and other means both treatment, can solve the medical community for many years of liver cancer treatment of intestinal problems. After nearly 600 cases of patients were followed up and found that postoperative 5-year survival rate rose to 50%, reaching the international advanced